摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-[(E,3S)-2-[(2Z,4E,6S,8R,9Z,12S,20R,21E,23Z,25Z,28S)-12-[(E,3S)-3-hydroxy-2-methylhex-4-en-2-yl]-20-methoxy-14,30-dioxo-7,13,17,29,33-pentaoxa-34,35-diazatetracyclo[29.2.1.115,18.06,8]pentatriaconta-1(34),2,4,9,15,18(35),21,23,25,31-decaen-28-yl]-2-methylhex-4-en-3-yl]oxy-4-oxobutanoic acid | 1011734-60-3

中文名称
——
中文别名
——
英文名称
4-[(E,3S)-2-[(2Z,4E,6S,8R,9Z,12S,20R,21E,23Z,25Z,28S)-12-[(E,3S)-3-hydroxy-2-methylhex-4-en-2-yl]-20-methoxy-14,30-dioxo-7,13,17,29,33-pentaoxa-34,35-diazatetracyclo[29.2.1.115,18.06,8]pentatriaconta-1(34),2,4,9,15,18(35),21,23,25,31-decaen-28-yl]-2-methylhex-4-en-3-yl]oxy-4-oxobutanoic acid
英文别名
——
4-[(E,3S)-2-[(2Z,4E,6S,8R,9Z,12S,20R,21E,23Z,25Z,28S)-12-[(E,3S)-3-hydroxy-2-methylhex-4-en-2-yl]-20-methoxy-14,30-dioxo-7,13,17,29,33-pentaoxa-34,35-diazatetracyclo[29.2.1.115,18.06,8]pentatriaconta-1(34),2,4,9,15,18(35),21,23,25,31-decaen-28-yl]-2-methylhex-4-en-3-yl]oxy-4-oxobutanoic acid化学式
CAS
1011734-60-3
化学式
C47H58N2O13
mdl
——
分子量
858.983
InChiKey
NJVVVHJVSRJAAE-WYPOEGQMSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    8.3
  • 重原子数:
    62
  • 可旋转键数:
    12
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.45
  • 拓扑面积:
    210
  • 氢给体数:
    2
  • 氢受体数:
    15

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • CONJUGATES OF DISORAZOLES AND THEIR DERIVATIVES WITH CELL-BINDING MOLECULES, NOVEL DISORAZOLE DERIVATIVES, PROCESSES OF MANUFACTURING AND USES THEREOF
    申请人:Guenther Eckhard
    公开号:US20080090758A1
    公开(公告)日:2008-04-17
    The present invention provides conjugates of disorazoles and their derivatives with cell-binding molecules, such as peptides, proteins, hormones, blood proteins and antibodies. The present invention further provides novel disorazole derivatives and processes of manufacturing such conjugates and disorazole derivatives. These compounds can be used as medicaments for the treatment of physiological and/or pathophysiological conditions in mammals, in particular for the treatment of various tumors.
  • US7741277B2
    申请人:——
    公开号:US7741277B2
    公开(公告)日:2010-06-22
  • US8470776B2
    申请人:——
    公开号:US8470776B2
    公开(公告)日:2013-06-25
查看更多